MAPT and Alzheimer disease: A follow‐up study found persist elevation of AD‐related plasma biomarkers including total‐tau, pTau181, inflammatory cytokines, NfL, neurogranin, etc. at 1 to 3 months after initial SARS‐CoV‐2 infection (Sun et al., 2021).